Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 633 clinical trials
None
Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer

positron emission tomography/computed tomography (PET/CT) to see if there is a better way to detect prostate cancer. Objective To develop improved techniques to

  • 30 views
  • 14 Nov, 2021
  • 1 location
None
Assessment of 18F-Florbetaben Whole-body PET for the Detection of Cardiac and Extracardiac Sites of Amyloid Deposits

strain pattern). Notwithstanding the above, relatively specific markers of amyloid plaques are now available in Positron Emission Tomography (PET). These markers are primarily fluorinated tracers

  • 0 views
  • 20 Aug, 2021
  • 1 location
None
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer

during a positron emission tomography/computed tomography (PET/CT) scan. This information might help guide future research and treatment. Objective To identify the

  • 0 views
  • 03 Nov, 2021
  • 1 location
None
Radium-223 in Biochemically Recurrent Prostate Cancer

and abdomen using radiation or magnetic resonance imaging. They will have a bone scan with injection of Tc99. They will have a positron emission tomography scan with intravenous (IV) injection of 18F

  • 0 views
  • 05 Dec, 2021
  • 1 location
None
Treating Severe Brain-injured Patients With Apomorphine

, circadian rhythm modifications using actimetry, core body temperature recording and night electroencephalography (EEG), positron emission tomography (PET), resting-state high-density EEG and functional

  • 8 views
  • 23 Jan, 2021
  • 2 locations
None
Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma

To evaluate the treatment outcome of unresectable soft tissue sarcoma using response based treatment

  • 0 views
  • 22 Jan, 2021
None
68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer

This phase I trial studies the side effects of 68GA-PSMA-11 PET imaging in patients with prostate cancer that has come back (recurrent). Gallium (68Ga) is a radiotracer that binds to a molecule, PSMA, that is found in abundance on most prostate cancer cells. PSMA is short for 'prostate specific membrane …

  • 2 views
  • 20 Feb, 2021
  • 1 location
None
Occupancy of Adenosine A2A Receptors Using the PET Radiotracer [18F]MNI-444

The overall goal of this protocol is to evaluate the binding of caffeine to adenosine A2A receptors in the brain of participants at risk for developing PD.

  • 0 views
  • 22 Aug, 2021
  • 1 location
None
Prediction of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage Using Dynamic 18F-FDG PET/CT

A pilot trial for assessing early microvascular alterations after aneurysmal subarachnoid hemorrhage using dynamic 18F-FDG PET/CT. The primary endpoint will be the measure of early changes in cerebral glucose uptake reflecting microperfusion.

  • 0 views
  • 13 Jul, 2021
  • 1 location
None
Span-C-SBRT for Pancreatic Cancer

To assess the freedom from local failure at 12 months after Stereotactic Body Radiotherapy (SBRT). Also to assess the safety, efficacy and feasibility of SBRT in the treatment of high risk localised pancreatic cancer.

  • 0 views
  • 04 Jun, 2021
  • 1 location